Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02693054
Other study ID # HALOCIP001
Secondary ID
Status Completed
Phase N/A
First received February 8, 2016
Last updated April 16, 2018
Start date April 2016
Est. completion date December 2016

Study information

Verified date April 2018
Source Sciton
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Characterizing safety and efficacy of Halo Laser Treatment for Various Skin Conditions.


Description:

The purpose of this study is to demonstrate safety and efficacy of Halo treatment as measured by changes in skin tone, texture and pigment.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Fitzpatrick Skin types I to IV

- Desires improvement of significant skin conditions on the face and/or neck

- Willingness to participate in the study by signing an informed consent form

- Will have limited sun exposure for at least two weeks prior to study screening and during the study, including the follow-up period

- Able to adhere to the treatment and follow-up schedule and post-treatment care instructions

- Post-menopausal or surgically sterilized female subjects.

Exclusion Criteria:

- History of Halo or resurfacing procedures in the treatment area within past six months

- Has tanned within the past thirty days or unable or unlikely to refrain from tanning, including the use of tanning booths, tanning spray, or cream

- Has tattoos, dysplastic nevi in the treatment area

- Pregnant and/or lactating

- Is planning to get pregnant within the study period

- Has a known history of photosensitivity

- Has used medication with photosensitizing properties within the past six months, e.g. isotretinoin

- History or evidence of chronic or recurring skin disease or disorder (e.g. psoriasis, --Netherton syndrome, etc.) affecting the treatment area

- Has open lacerations, abrasions, active cold sores, or herpes sores

- Has hormonal disorders

- History of keloid or hypertrophic scar formation or poor wound healing

- History of immunosuppression or immune deficiency disorder (including HIV infection or AIDS) or use of immunosuppressive medications

- History of bleeding disorder or taking anticoagulation medications

- History of skin cancer or any other cancer in the treatment area

- Has significant concurrent illnesses, such as diabetes, lupus, epilepsy, or cardiac disorders, which might be aggravated as a result of treatment

- Has participated in any clinical trial involving an investigational drug or cosmetic product or procedure within the past thirty days

- The investigator feels that for any reason the subject is not eligible to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
HALO
Laser Treatment

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sciton

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement in skin conditions assessed by photographs Assessment of photographs by blinded evaluators 6 months
Secondary Subject satisfaction post final treatment Assessment of subject satisfaction with treatment result using survey/questionnaire 3 months
See also
  Status Clinical Trial Phase
Terminated NCT03573076 - Treatment of Photodamaged Skin of the décolleté Phase 4
Suspended NCT03963102 - Duration of Ameluz Application in Acral Actinic Keratoses Response Phase 4
Completed NCT01283464 - Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles Phase 2
Active, not recruiting NCT06170346 - Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced Phase 2
Completed NCT02736760 - Daylight-PDT With MAL for AK and Photodamaged Skin Phase 4
Active, not recruiting NCT05456334 - New Treatments for Actinic Keratoses of the Scalp N/A
Completed NCT05423873 - A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging N/A
Completed NCT03095872 - Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy Phase 3
Not yet recruiting NCT05908825 - Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults N/A
Active, not recruiting NCT05963204 - A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator With a Skincare Regimen N/A
Recruiting NCT04523961 - Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face Phase 2/Phase 3
Completed NCT01787461 - A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure Phase 4
Recruiting NCT06351358 - Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies N/A
Completed NCT04065035 - A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming N/A
Active, not recruiting NCT04096742 - Altreno for Chest Rejuvenation Phase 4
Terminated NCT00375141 - Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation. N/A